Anzeige
+++Elevate Service Group: Die Lizenz, über die niemand spricht, und warum Wettbewerber keine bekommen+++
Portfolio Tracker
Alle Depots an einem Ort. Dein Gesamtvermögen immer im Blick, tiefgründige Renditeanalysen und Dividendenplaner.
Anzeige
EQS-News

European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2023 25.04.2024, 16:25 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
EHC B.V. Registered (A) 9,10 EUR +1,11 % Baader Bank
Kostenlose Aktienchance per SMS Ausgewählte Trading-Einschätzungen aufs Handy.

EQS-News: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Annual Report
European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2023

25.04.2024 / 16:25 CET/CEST
The issuer is solely responsible for the content of this announcement.


European Healthcare Acquisition & Growth Company B.V.  publishes its annual report for the financial year 2023 

Amsterdam, 25 April 2024

Today, European Healthcare Acquisition & Growth Company B.V. ("EHC"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam, publishes its annual report for the financial year 2023 (the "Annual Report 2023"), including its financial statements and the report of its board.

The Annual Report 2023 relates to the financial year 2023, from 1 January 2023 to 31 December 2023,

The Annual Report 2023 can be downloaded from the website of EHC in the 'Investor Relations' section under 'News & Publications', under 'Reports': www.ehc-company.com, where a downloadable version in the European Single Electronic Format (ESEF) is also available.

The annual general meeting of shareholders of EHC will be held during the second half of Q2 2024, at which the Annual Report 2023 will be discussed. The agenda of the AGM will be published in due course.

European Healthcare Acquisition & Growth Company B.V.

 

General Enquiries

+49 (0) 89 4523240

info@ehc-company.com

 

Media Enquiries

FGS Global

Kai Peter Rath

+49 211 43079-209

kai.rath@fgsglobal.com

 

Disclaimer

This press release, and the Annual Report 2023, may include forward-looking statements, which are based on EHC's current expectations and projections about future events and speak only as of the date hereof. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not within or outside the control of EHC. Such factors may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. Accordingly, no undue reliance should be placed on any forward-looking statements. EHC operates in a rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor to assess the impact that these factors will have on EHC. Forward-looking statements speak only as at the date at which they are made and EHC undertakes no obligation to update these forward-looking statements. Further reference is made to the risk factors in the Annual Report 2023.

 

This press release contains information that may qualify as inside information within the meaning of Article 7, paragraph 1, of the EU Market Abuse Regulation.



25.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: European Healthcare Acquisition & Growth Company B.V.
c/o ALR Treuhand GmbH; Theresienhöhe 28
80339 München
Germany
ISIN: NL0015000K10, NL0015000K28
WKN: A3C60V
Listed: Regulated Unofficial Market in Frankfurt, Munich, Stuttgart; Amsterdam
EQS News ID: 1888351

 
End of News EQS News Service

1888351  25.04.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1888351&application_name=news&site_id=boersennews
Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer